Comcast Doesn't Doom Avandia Insurer Class, Judge Told

Law360, Philadelphia (March 14, 2014, 3:42 PM EDT) -- The U.S. Supreme Court’s Comcast Corp. v. Behrend decision does not bar class certification in a suit by two Humana Inc. units seeking damages from GlaxoSmithKline PLC for costs from treating certain Medicare patients allegedly harmed by the drug Avandia, a Pennsylvania federal judge heard Friday.

Richard Cohen, an attorney with Lowey Dannenberg Cohen & Hart PC representing the insurers, argued that his case dealt simply with claims that GSK violated its statutory requirement to reimburse Medicare Advantage organizations, or MAOs, for the cost of treating...
To view the full article, register now.

Related

Sections

Case Information

Case Title

HUMANA MEDICAL PLAN, INC. et al v. GLAXOSMITHKLINE, L.L.C. et al


Case Number

2:10-cv-06733

Court

Pennsylvania Eastern

Nature of Suit

P.I.: Personal Inj. Prod. Liability

Judge

CYNTHIA M. RUFE

Date Filed

November 17, 2010

Law Firms

Companies

Government Agencies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.